Home » News » Currently Reading:

McKesson To Buy US Oncology for $2.16 Billion

November 1, 2010 News 2 Comments


McKesson announced this morning that it will buy US Oncology in a deal valued at $2.16 billion, including debt, from its private equity owners. The transaction is expected to close by December 31.

McKesson says the acquisition will have a modestly positive impact on its earnings starting in FY2012.

US Oncology, based in The Woodlands, TX, has annual revenue of around $3.5 billion and has relationships with 1,300 community-based oncologists. Its technology offerings include the iKnowMed oncology EHR, a physician collaboration portal, and clinical trials matching.

McKesson chairman and CEO John Hammergren said this about the acquisition:

McKesson is committed to improving the health and vitality of our customers, with the ultimate goal of improving the health of patients. The combination of US Oncology and McKesson will enhance our ability to achieve these goals in one of the most important segments in healthcare. Community oncology practices need strategic support that offers not only technology and distribution solutions, but also value-added clinical and reimbursement management services that enable them to provide the highest-quality, most efficient care to their patients. With this acquisition, McKesson will offer a compelling suite of services and solutions to community oncologists and other partners in the rapidly evolving specialty business.

US Oncology CEO Bruce Broussard, who will stay on to run the new McKesson unit, was quoted as saying,

With the health-care marketplace moving rapidly toward reimbursement based on quality and cost-effectiveness, our physician customers need access to deep clinical, operational and information technology capabilities to create integrated networks that continually enhance the quality of care in a cost-efficient manner. In joining McKesson, we are building the scale and expertise necessary to empower our customer base to shape the future of health care.

View/Print Text Only View/Print Text Only

HIStalk Featured Sponsors


Currently there are "2 comments" on this Article:

  1. Cancer Care is big business. Many have been enriched. Are too many patients with futile illness being sold snake oil?

Subscribe to Updates



Text Ads

Report News and Rumors

No title

Anonymous online form
Rumor line: 801.HIT.NEWS



Founding Sponsors


Platinum Sponsors


































































Gold Sponsors




















Reader Comments

  • Alicia Brubaker: I was also surprised by the report from KLAS in regards to Meditech Sepsis surveillance tools. I work for a 451 bed acu...
  • dzamd: "go walkabout"---heh, good one...
  • MC: Depending on the company/culture, email can often be treated as a synchronous message where a response is expected even ...
  • Fourth Hansen Brrother: In the history of paper based charting, there were apparently plenty of instances of gang bangers entering hospitals and...
  • PM_from_haities: Pretty sure in the history of paper based charting a terrorist never came in took over a hospital and locked the filing ...

Sponsor Quick Links